Control_vs_Immune_Tolerant

Control vs Immune Tolerant

p-value ≤ 0.05 5 significant 2025-09-26 00:00:00 Study: MTBLS280
38 Total Features
5 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS280_0004_00000001
Linked study
MTBLS280 — Metabolic characterization of the natural progression of chronic hepatitis B (Biogenic amine and Acyl-carnitine assays).
Comparison
Control vs Immune Tolerant
Group A
Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.
Group B
Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.
Total features tested
38
Significant features
5
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
YGPSJZOEDVAXAB-QMMMGPOBSA-N (2<i>S</i>)-4-(2-aminophenyl)-2-ammonio-4-oxobutanoate up 1.718 4.72e-05
ZDGJAHTZVHVLOT-YUMQZZPRSA-N L-Saccharopine up 1.66 0.00199
JBFYFLXEJFQWMU-WDSKDSINSA-N γ-<small>L</small>-Glu-<small>L</small>-Gln up 1.69 0.0028
PMMYEEVYMWASQN-UHFFFAOYSA-N 4Hyp down 0.5936 0.0212
MCYHPZGUONZRGO-VKHMYHEASA-N O-METHYLCYSTEINE down 0.6052 0.0247